Ics Opportunities II LLC insider trades: Sensei Biotherapeutics (SNSE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ics Opportunities II LLC reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | SNSE | ↓ Sell | 17,076 | $31.51 | $538K | Indirect | May 15, 2026 (38d) |
| Apr 7, 2026 | SNSE | ↑ Buy | 4,215 | $33.54 | $141K | Indirect | May 15, 2026 (38d) |
| Apr 1, 2026 | SNSE | ↑ Buy | 12,180 | $31.37 | $382K | Indirect | May 15, 2026 (44d) |
| Apr 1, 2026 | SNSE | ↓ Sell | 2,741 | $28.07 | $77K | Indirect | May 15, 2026 (44d) |
| Mar 30, 2026 | SNSE | ↑ Buy | 30,585 | $26.75 | $818K | Indirect | May 15, 2026 (46d) |
| Mar 30, 2026 | SNSE | ↓ Sell | 3,250 | $27.50 | $89K | Indirect | May 15, 2026 (46d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SNSE insiders
Open-market trades in the last 12 months
About Ics Opportunities II LLC's insider trades
Ics Opportunities II LLC is a 10% owner of Sensei Biotherapeutics (SNSE). Since Mar 30, 2026, it has reported 3 open-market purchases worth $1.3M and 3 sales worth $704K on SEC Form 4. In the last 12 months: 3 buys ($1.3M) and 3 sales ($704K).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNSE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.